|
NUP54 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.355700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.993900E-04 |
| Normal-vs-Stage2 |
1.831410E-01 |
| Normal-vs-Stage3 |
9.833000E-01 |
| Normal-vs-Stage4 |
8.554000E-01 |
| Stage1-vs-Stage2 |
5.453000E-01 |
| Stage1-vs-Stage3 |
6.584300E-04 |
| Stage1-vs-Stage4 |
6.681400E-03 |
| Stage2-vs-Stage3 |
1.845360E-01 |
| Stage2-vs-Stage4 |
2.548200E-01 |
| Stage3-vs-Stage4 |
8.653600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.692180E-02 |
| Normal-vs-AfricanAmerican |
8.993400E-01 |
| Normal-vs-Asian |
2.201000E-01 |
| Caucasian-vs-AfricanAmerican |
1.408350E-01 |
| Caucasian-vs-Asian |
7.859600E-01 |
| AfricanAmerican-vs-Asian |
3.554400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.652000E-02 |
| Normal-vs-Female |
2.972000E-02 |
| Male-vs-Female |
6.323800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.947600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.236500E-02 |
| Normal-vs-Age(61-80Yrs) |
4.249700E-02 |
| Normal-vs-Age(81-100Yrs) |
9.860600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.395000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.142600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.599400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.698200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.973800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.789200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.640800E-04 |
| Normal-vs-Grade 2 |
8.16040000000129E-05 |
| Normal-vs-Grade 3 |
5.948400E-01 |
| Normal-vs-Grade 4 |
2.738200E-01 |
| Grade 1-vs-Grade 2 |
3.307800E-01 |
| Grade 1-vs-Grade 3 |
1.855200E-03 |
| Grade 1-vs-Grade 4 |
2.663400E-03 |
| Grade 2-vs-Grade 3 |
3.70219999999977E-05 |
| Grade 2-vs-Grade 4 |
4.44619999999674E-05 |
| Grade 3-vs-Grade 4 |
1.047960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.41919999985652E-07 |
| Normal-vs-ccB subtype |
9.962800E-01 |
| ccA subtype-vs-ccB subtype |
6.2376000031783E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.476200E-02 |
| Normal-vs-N1 |
8.172400E-01 |
| N0-vs-N1 |
3.046000E-01 |
|
|
